Integrated Hepatitis C Care for People Who Inject Drugs (Heplink): Protocol for a Feasibility Study in Primary Care

BACKGROUND: Hepatitis C virus (HCV) infection is a major cause of chronic liver disease and death. Drug use remains the significant cause of new infections in the European Union, with estimates of HCV antibody prevalence among people who inject drugs ranging from 5% to 90% in 29 European countries....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JMIR Res Protoc
Main Authors: McCombe, Geoff, Swan, Davina, O’Connor, Eileen, Avramovic, Gordana, Vickerman, Peter, Ward, Zoe, Surey, Julian, Macías, Juan, Lambert, John S, Cullen, Walter
Formato: Artigo
Idioma:Inglês
Publicado em: JMIR Publications 2018
Assuntos:
Protocol
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6006011/
https://ncbi.nlm.nih.gov/pubmed/29866641
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2196/resprot.9043
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados